Enhancing the GLP‐1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
J. Neurochem. (2010) 113, 1621–1631. Increasing evidence suggests that glucagon‐like peptide‐1 (GLP‐1), an incretin hormone of current interest in type 2 diabetes, is neuroprotective in both cell culture and animal models. To characterize the neuroprotective properties of GLP‐1 and associated underlying mechanisms, we over‐expressed the GLP‐1 receptor (GLP‐1R) on human neuroblastoma SH‐SY5Y cells to generate a neuronal culture system featuring enhanced GLP‐1R signaling. In GLP‐1R over‐expressing SH‐SY5Y (SH‐hGLP‐1R#9) cells, GLP‐1 and the long‐acting agonist exendin‐4 stimulated cell proliferation and increased cell viability by 2‐fold at 24 h at physiologically relevant concentrations. This GLP‐1R‐dependent action was mediated via the protein kinase A and phosphoinositide 3‐kinase signaling pathways, with the MAPK pathway playing a minor role. GLP‐1 and exendin‐4 pretreatment dose‐dependently protected SH‐hGLP‐1R#9 cells from hydrogen peroxide (H 2 O 2)‐ and 6‐hydroxydopamine‐induced cell death. This involved amelioration of elevated caspase 3 activity, down‐regulation of pro‐apoptotic Bax and up‐regulation of anti‐apoptotic Bcl‐2 protein. In the presence of 6‐hydroxydopamine, GLP‐1’s ability to lower caspse‐3 activity was abolished with the phosphoinositide 3‐kinase inhibitor, LY2940002, and partly reduced with the protein kinase A inhibitor, H89. Hence, GLP‐1R mediated neurotrophic and anti‐apoptotic actions co‐contribute to the neuroprotective property of GLP‐1 in neuronal cell cultures, and reinforce the potential therapeutic value of GLP‐1R agonists in neurodegenerative disorders involving oxidative stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639 · cited 5×
“For the MTS assay, SH-SY5Y cells in 96-well plates were serumstarved for 24 h before pre-treatment with various concentrations of GLP-1, Ex-4 or Ex-4 + Ex9-39 [a selective GLP-1R antagonist (Li et al. 2003; Baggio and Drucker 2007)] for 2 h.”
BackgroundMethodInfluentialOxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614
Harding, H. P., Zhang, Y., Bertolotti, A., Zeng, H., & Ron, D. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80330-5 · Cited by 2,021
Zander, M., Madsbad, S., Madsen, J. L., & Holst, J. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07952-7 · Cited by 1,297 · cited 1×
“…(4.8 pmol kg)1 min)1) that achieved substantial clinical improvements in type 2 diabetics was associated with GLP-1 plasma levels of 60–70 pmol/ L (Zander et al. 2002; Drucker and Nauck 2006), and a clinically effective dose of Ex-4 (Kolterman et al. 2005) is associated with plasma…”
BackgroundInfluentialGlucagon-like Peptide-1 Receptor Signaling Modulates β Cell Apoptosis
Li, Y., Hansotia, T., Yusta, B., Ris, F., Halban, P. A., & Drucker, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209423200 · Cited by 589 · cited 3×
“…Ex-4 to the GLP-1R leads to its interaction with the guanine triphosphate (GTP)-binding protein Gs, resulting in the activation of adenylyl cyclase and increased production of intracellular cAMP in the pancreas (Li et al. 2003), which has likewise been confirmed in PC 12 cells (Perry et al. 2002b).”
BackgroundMethodSelf-citationLi, Y., Perry, T., Kindy, M. S., Harvey, B. K., Tweedie, D., Holloway, H. W., Powers, K., Shen, H., Egan, J. M., Sambamurti, K., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806720106 · Cited by 589 · cited 6×
“…activity in a variety of animal models of acute and chronic neurologic conditions (Perry et al. 2003; Perry and Greig 2004; Perry et al. 2007; Gault and Hölscher 2008; Li et al. 2010), including 6-OHDA- and MPTP-induced PD (Bertilsson et al. 2008; Harkavyi et al. 2008; Li et al. 2009).”
BackgroundSelf-citationProtection and Reversal of Excitotoxic Neuronal Damage by Glucagon-Like Peptide-1 and Exendin-4
Perry, T., Haughey, N. J., Mattson, M. P., Egan, J. M., & Greig, N. H. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.037481 · Cited by 380
Self-citationBertilsson, G., Patrone, C., Zachrisson, O., Andersson, A., Dannaeus, K., Heidrich, J., Kortesmaa, J., Mercer, A., Nielsen, E., Rönnholm, H., et al. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21483 · Cited by 345
Hamilton, A., & Hölscher, C. (2009) · NeuroReport · doi:10.1097/wnr.0b013e32832fbf14 · Cited by 227
Cited by
Graaf, C. D., Donnelly, D., Wootten, D., Lau, J., Sexton, P. M., Miller, L. J., Ahn, J.-M., Liao, J., Fletcher, M. M., Yang, D., et al. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011395 · Cited by 403
Kopp, K. O., Glotfelty, E. J., Li, Y., & Greig, N. H. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106550 · Cited by 298
Self-citationParkinson's disease, insulin resistance and novel agents of neuroprotection
Aviles-Olmos, I., Limousin, P., Lees, A., & Foltynie, T. (2013) · Brain · doi:10.1093/brain/aws009 · Cited by 283
Salcedo, I., Tweedie, D., Li, Y., & Greig, N. H. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01971.x · Cited by 259
Self-citationAthauda, D., Gulyani, S., Karnati, H. K., Li, Y., Tweedie, D., Mustapic, M., Chawla, S., Chowdhury, K., Skene, S. S., Greig, N. H., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2018.4304 · Cited by 258
Self-citation
Metadata
- Authors
- Li, Y., Tweedie, D., Mattson, M. P., Holloway, H. W., & Greig, N. H.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2010-06
- Volume
- 113
- Issue
- 6
- Pages
- 1621-1631
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1535374793
- Cited by
- 150
- References
- 11
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Enhancing the GLP‐1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells. https://app.cochat.ai/papers/10.1111/j.1471-4159.2010.06731.x
- The paper
- Li, Y., Tweedie, D., Mattson, M. P., Holloway, H. W., & Greig, N. H. (2010). Enhancing the GLP‐1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2010.06731.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.